Literature DB >> 21339500

Local amygdala structural differences with 3T MRI in patients with Alzheimer disease.

E Cavedo1, M Boccardi, R Ganzola, E Canu, A Beltramello, C Caltagirone, P M Thompson, G B Frisoni.   

Abstract

OBJECTIVE: Histologic studies show that the amygdala is affected by Alzheimer disease (AD) pathology, and its medial aspect is the most involved. We aimed to assess in vivo local structural differences in the amygdala of patients with AD using high-field MRI.
METHODS: A total of 19 patients with AD (mean age 76, SD 6 years, mean Mini-Mental State Examination score [MMSE] 13, SD 4) and 19 healthy elderly controls (age 74, SD 5, MMSE 29, SD 1) were enrolled. The radial atrophy mapping technique was used to reconstruct the 3-dimensional surface of the amygdala. Maps of surface tissue loss in patients with AD vs controls were computed and statistically tested with permutation tests thresholded at p < 0.05, to correct for multiple comparisons. A digital atlas of the amygdalar nuclei was used to infer which nuclei were involved.
RESULTS: Both amygdalar volumes were significantly smaller in patients with AD (right 1,508 mm³, SD 418; left 1,646, SD 419) than controls (right 2,129 mm³, SD 316; left 2,077, SD 376; p < 0.002). In the dorsomedial part, significant local tissue loss (20%-30%) was mapped in the medial and central nuclei. Ventrally, the lateral nucleus (La) and the basolateral ventral medial nucleus (BLVM) were also involved (20%-30% loss).
CONCLUSIONS: We found in vivo local structural differences in the amygdala of patients with AD. The nuclei involved have known connections to the hippocampus (BLVM, La) and olfactory system (medial nucleus) and with cholinergic pathways (central nucleus). This pattern is consistent with the known pathophysiology of neural systems affected by AD.

Entities:  

Mesh:

Year:  2011        PMID: 21339500      PMCID: PMC3053328          DOI: 10.1212/WNL.0b013e31820d62d9

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  34 in total

1.  Cognitive and neural mechanisms of emotional memory.

Authors:  S Hamann
Journal:  Trends Cogn Sci       Date:  2001-09-01       Impact factor: 20.229

2.  In vivo neuropathology of the hippocampal formation in AD: a radial mapping MR-based study.

Authors:  G B Frisoni; F Sabattoli; A D Lee; R A Dutton; A W Toga; P M Thompson
Journal:  Neuroimage       Date:  2006-05-02       Impact factor: 6.556

Review 3.  Comparative aspects of amygdala connectivity.

Authors:  Joseph L Price
Journal:  Ann N Y Acad Sci       Date:  2003-04       Impact factor: 5.691

4.  Alzheimer's neurofibrillary changes. A topographic study.

Authors:  A HIRANO; H M ZIMMERMAN
Journal:  Arch Neurol       Date:  1962-09

5.  Pathological alterations in the amygdala in Alzheimer's disease.

Authors:  L J Kromer Vogt; B T Hyman; G W Van Hoesen; A R Damasio
Journal:  Neuroscience       Date:  1990       Impact factor: 3.590

Review 6.  Olfactory deficits in Alzheimer's disease.

Authors:  M Serby
Journal:  J Neural Transm Suppl       Date:  1987

7.  Volumetry of amygdala and hippocampus and memory performance in Alzheimer's disease.

Authors:  Michael Basso; John Yang; Lauren Warren; Martha G MacAvoy; Pradeep Varma; Richard A Bronen; Christopher H van Dyck
Journal:  Psychiatry Res       Date:  2006-03-09       Impact factor: 3.222

8.  Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes.

Authors:  C F Lippa; H Fujiwara; D M Mann; B Giasson; M Baba; M L Schmidt; L E Nee; B O'Connell; D A Pollen; P St George-Hyslop; B Ghetti; D Nochlin; T D Bird; N J Cairns; V M Lee; T Iwatsubo; J Q Trojanowski
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

9.  Memory with emotional content, brain amygdala and Alzheimer's disease.

Authors:  R R Schultz; C C de Castro; P H F Bertolucci
Journal:  Acta Neurol Scand       Date:  2008-12-22       Impact factor: 3.209

10.  The distribution pattern of pathology and cholinergic deficits in amygdaloid complex in Alzheimer's disease and dementia with Lewy bodies.

Authors:  Huseyin A Sahin; Murat Emre; Iryna Ziabreva; Elaine Perry; Bulent Celasun; Robert Perry
Journal:  Acta Neuropathol       Date:  2006-02-09       Impact factor: 17.088

View more
  29 in total

1.  Morphological changes in subregions of hippocampus and amygdala in major depressive disorder patients.

Authors:  Zhijun Yao; Yu Fu; Jianfeng Wu; Wenwen Zhang; Yue Yu; Zicheng Zhang; Xia Wu; Yalin Wang; Bin Hu
Journal:  Brain Imaging Behav       Date:  2020-06       Impact factor: 3.978

2.  Regional analysis of the magnetization transfer ratio of the brain in mild Alzheimer disease and amnestic mild cognitive impairment.

Authors:  M Mascalchi; A Ginestroni; V Bessi; N Toschi; S Padiglioni; S Ciulli; C Tessa; M Giannelli; L Bracco; S Diciotti
Journal:  AJNR Am J Neuroradiol       Date:  2013-06-06       Impact factor: 3.825

3.  Individual subject classification of mixed dementia from pure subcortical vascular dementia based on subcortical shape analysis.

Authors:  Hee Jin Kim; Jeonghun Kim; Hanna Cho; Byoung Seok Ye; Cindy W Yoon; Young Noh; Geon Ha Kim; Jae Hong Lee; Jae Seung Kim; Yearn Seong Choe; Kyung-Han Lee; Chang-Hun Kim; Sang Won Seo; Michael W Weiner; Duk L Na; Joon-Kyung Seong
Journal:  PLoS One       Date:  2013-10-10       Impact factor: 3.240

4.  The diffeomorphometry of regional shape change rates and its relevance to cognitive deterioration in mild cognitive impairment and Alzheimer's disease.

Authors:  Xiaoying Tang; Dominic Holland; Anders M Dale; Laurent Younes; Michael I Miller
Journal:  Hum Brain Mapp       Date:  2015-02-03       Impact factor: 5.038

5.  Amygdala Atrophy in MCI/Alzheimer's Disease in the BIOCARD cohort based on Diffeomorphic Morphometry.

Authors:  Michael I Miller; Laurent Younes; J Tilak Ratnanather; Timothy Brown; Tommy Reigel; Huong Trinh; Xiaoying Tang; Peter Barker; Susumu Mori; Marilyn Albert
Journal:  Med Image Comput Comput Assist Interv       Date:  2012-10

6.  Shape abnormalities of subcortical and ventricular structures in mild cognitive impairment and Alzheimer's disease: detecting, quantifying, and predicting.

Authors:  Xiaoying Tang; Dominic Holland; Anders M Dale; Laurent Younes; Michael I Miller
Journal:  Hum Brain Mapp       Date:  2014-01-17       Impact factor: 5.038

7.  Amygdalar atrophy in symptomatic Alzheimer's disease based on diffeomorphometry: the BIOCARD cohort.

Authors:  Michael I Miller; Laurent Younes; J Tilak Ratnanather; Timothy Brown; Huong Trinh; David S Lee; Daniel Tward; Pamela B Mahon; Susumu Mori; Marilyn Albert
Journal:  Neurobiol Aging       Date:  2014-08-29       Impact factor: 4.673

Review 8.  Revolution of Alzheimer Precision Neurology. Passageway of Systems Biology and Neurophysiology.

Authors:  Harald Hampel; Nicola Toschi; Claudio Babiloni; Filippo Baldacci; Keith L Black; Arun L W Bokde; René S Bun; Francesco Cacciola; Enrica Cavedo; Patrizia A Chiesa; Olivier Colliot; Cristina-Maria Coman; Bruno Dubois; Andrea Duggento; Stanley Durrleman; Maria-Teresa Ferretti; Nathalie George; Remy Genthon; Marie-Odile Habert; Karl Herholz; Yosef Koronyo; Maya Koronyo-Hamaoui; Foudil Lamari; Todd Langevin; Stéphane Lehéricy; Jean Lorenceau; Christian Neri; Robert Nisticò; Francis Nyasse-Messene; Craig Ritchie; Simone Rossi; Emiliano Santarnecchi; Olaf Sporns; Steven R Verdooner; Andrea Vergallo; Nicolas Villain; Erfan Younesi; Francesco Garaci; Simone Lista
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

9.  BIOMARKER CHANGE-POINT ESTIMATION WITH RIGHT CENSORING IN LONGITUDINAL STUDIES.

Authors:  Xiaoying Tang; Michael I Miller; Laurent Younes
Journal:  Ann Appl Stat       Date:  2017-09       Impact factor: 2.083

10.  Regionally specific increased volume of the amygdala in Williams syndrome: evidence from surface-based modeling.

Authors:  Brian W Haas; Kristen Sheau; Ryan G Kelley; Paul M Thompson; Allan L Reiss
Journal:  Hum Brain Mapp       Date:  2012-11-14       Impact factor: 5.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.